Navigation Links
Vietnam Plans Human Trial of Bird Flu Vaccine

Vietnam plans to start its first human trial of a locally-made H5N1 bird flu vaccine as early as next month, using 20 to 30 volunteers, said health officials in the communist country. The drug trial, to be carried out with US government technical assistance, will be the latest of several global efforts to develop a vaccine for mass production, with research also going on in the United States, Europe and Asia.

The news comes as a new wave of bird flu sweeping Vietnam has killed a 20-year-old man, infected four other people and triggered more than 100 poultry outbreaks nationwide since last month. "Preparations for the clinical test of a human vaccine have been basically completed," said Nguyen Tran Hien, director of the National Institute of Hygiene and Epidemiology (NIHE) in Hanoi.

"Twenty to 30 volunteers will be chosen to test an H5N1 vaccine produced in Vietnam." Hien said he expected testing to start as early as next month, pending health ministry approval, with the trial expected to wrap up next year. In the tests, subjects would not be exposed to H5N1 -- the viral strain that has killed 191 people worldwide since 2003 -- but would be given the vaccine to look for early evidence of safety and test their antibody response. US experts would provide technical assistance, said US Health Attache Michael Iademarco, adding Washington had granted one million dollars to Vabiotech, a company spun off from the institute.

The Vietnam trial is one of several efforts worldwide to find a vaccine that could be mass produced in case of a pandemic. Last month Indonesia's health ministry said US company Baxter Healthcare would in July start clinical trials of a bird flu vaccine in Singapore and Hong Kong, using a strain of the virus found in Indonesia. "There are many candidate vaccines, and some have been approved for stockpiling in emergency use," said Iademarco. But he said the long-term challenge was to "develop the capacity for rapi
'"/>




Page: 1 2

Related medicine news :

1. WHO Declares Vietnam First Country to Control SARS
2. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
3. Vaccination to fowl in Vietnam reduced the spread of bird flu
4. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
5. Bird flu virus spreading in Vietnam
6. Vietnam administers Bird flu vaccination to all birds
7. Chirps of Wisdom: Taking a Leaf out Of Vietnam’s Bird-Flu Sag
8. Link Between Vietnam Service And Prostate Cancer Is Statistically Insignificant
9. Rubella Outbreak Grips Vietnam
10. WHO Praises Singapore and Vietnam but Slams China With Respect To Tackling SARS
11. Foot and Mouth Raises Its Ugly Head in Vietnam
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vietnam Plans Human Trial Bird Flu Vaccine

(Date:8/20/2014)... August 20, 2014 Doctors at the University ... wipe out mesothelioma in laboratory mice by injecting them with ... posted details of the study on its website. Click ... with Hong Kong University’s AIDS Institute of Microbiology created a ... or PD-1. By altering DNA, the vaccine is designed to ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 Online ... for 2015. , According to Zane Benefits, with open ... employees are encouraged to start thinking about their healthcare ... open enrollment period will run from November 15, 2014 ... can purchase a new individual health insurance policy, or ...
(Date:8/20/2014)... 20, 2014 The report “Automotive ... - A Global Analysis: by Geography - Trends ... classifies and defines automotive airbag and seatbelt market ... highlights potential growth opportunities in the coming years ... market drivers, restrains, growth indicators, challenges, legislation trends, ...
(Date:8/20/2014)... August 20, 2014 In a recent ... a University College London (UCL) study showed that dental ... method of brushing teeth was the most effective. Analysis ... different tooth-brushing techniques were frequently recommended, but none were ... for Cosmetic Dentistry, experienced cosmetic dentist Dr. ...
(Date:8/20/2014)... Hope For The Warriors® is excited to announce ... in Washington, DC on Thursday, October 2, 2014 at ... the courage of our wounded service members, their families, ... Got Heart, Give Hope® Celebration will benefit Hope For ... sense of self, restoring the family unit, and restoring ...
Breaking Medicine News(10 mins):Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2
... May 19 Towards the Electronic,Patient Record ... interface terminology,announced today its next-generation interface terminology ... terminologies access to all of,IMO,s terminology knowledge ... algorithms optimized for millisecond response times in ...
... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced ... Burn Dressing, its flagship wound care,product, was profiled ... Reporter Lisa Thomas-Laury examines the use of ... Leonard Abrams Center for Advanced Wound,Healing of the ...
... Health, Inc., one of,the nation,s largest public/private health ... provider of software agent,technologies for health information exchange, ... clinicians at the point of care., Shared ... the clinical,interface capabilities of what is already one ...
... Should Be ,Wake-Up Call, for Doctors and Women, WASHINGTON, ... coronary artery disease are significantly less likely than,men to be ... WomenHeart - the national coalition for women with heart,disease -- ... sure,that women are getting the care that they need., ...
... May 19 Edifecs, the leader in ... EDS has,selected the Edifecs Healthcare Accelerator Suite ... health care transactions in both,real-time and batch ... of the,EDS MetaVance(R) Administration and Finance System., ...
... of Liverpool has performed a groundbreaking operation on a chimp ... dogs. , The three year-old chimp called Janet was rescued ... in a chimpanzee reserve supported by the Cameroon Wildlife Aid ... because a bone in her forearm - the ulna - ...
Cached Medicine News:Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Derma Sciences' MEDIHONEY(TM) Profiled By ABC News' Philadelphia Affiliate 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 3Health News:Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks 2Health News:EDS Selects Edifecs Healthcare Accelerator Suite for Claims Processing Solution 2Health News:Surgeon operates to rescue chimp with rare deformity 2
(Date:8/20/2014)... Glenmark Pharmaceuticals S.A. (GPSA), ... India (GPL), announces the discovery and initiation of ... candidate, GBR 1302, a HER2xCD3 bispecific antibody. GBR ... Biologics Research Centre located in La Chaux-de-Fonds, ... on Glenmark,s innovative BEAT antibody technology platform which ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
(Date:8/19/2014)... -- Minimally Invasive Devices Inc. (MID), a ... that Mitsubishi Corporation has formally agreed to exclusively distribute ... Japan . MID anticipates that FloShield will ... in the second half of 2015. ... Storz GMBH & Co. (endoscopic instruments and devices) in ...
Breaking Medicine Technology:Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... achieve undetectable viral load in Phase,IIa trial within ... care, SAN FRANCISCO, Nov. 1 New ... protease inhibitor (PI) being,developed by Tibotec BVBA for ... Tibotec will present findings from three TMC435 studies,including ...
... Higher Sustained Virological Response Rates Recognized as Marker ... 1 A new,independently-conducted study being presented at ... the Study of Liver Diseases (AASLD) shows that,PEGASYS(R) ... response (SVR) rates for hepatitis C patients as,compared ...
Cached Medicine Technology:Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... CheckPoint is an automated, wireless, computerized ... alert system for refrigerator, freezer, incubator ... recorders, data loggers and manual temperature ... an existing PC and comes complete ...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
Medicine Products: